1. Background {#sec200294}
=============

Recombinant human endostatin (rhES) is one of the most common inhibitors of angiogenesis. It has been reported that endostatin inhibits different kinds of tumors with low toxicity and drug resistance in long-term applications, and rhES has been approved by the state food and drug administration of China as a specific drug for non-small-cell lung cancer therapy ([@A34091R1]). The rhES protein has been expressed by eukaryotic and prokaryotic expression systems, including yeast, mammalian cells, insect cells, baculovirus, and *Escherichia coli* ([@A34091R2], [@A34091R3]).

The *E. coli* expression system is the most widely used host for recombinant protein production ([@A34091R4]). Culture conditions, such as induction time, inducer concentration, temperature, and post-induction time, play important roles in recombinant protein expression ([@A34091R5]). Transcription of a cloned gene is the first step in protein expression, so each factor that influences mRNA concentration leads to increased or decreased protein expression ([@A34091R6]). Therefore, evaluating the contributing factors is necessary to improve the yield of mRNA levels of cloned genes.

The one-factor-at-a-time technique is a conventional approach to optimizing culture conditions, in which a single parameter is evaluated while all of the other parameters are fixed at a given set of conditions. However, this method possesses some limitations; for example, it is time-consuming and it ignores the interactions between the influencing parameters ([@A34091R7]). To overcome these limitations, other methods, such as response surface methodology (RSM), can be used. RSM can determine the individual role of each parameter, and its influence on the other parameters ([@A34091R8]). It is a mathematical and statistical tool that has been successfully used for experimental design and modeling, for evaluating the effects of several parameters at once, and for optimizing biochemical and biotechnological processes. In addition, the Box-Behnken design (BBD) is a valuable model of RSM for evaluating different variables' interactions, with relatively few runs ([@A34091R9], [@A34091R10]).

2. Objectives {#sec200295}
=============

The present study aimed to obtain the highest hES mRNA level under optimal culture conditions. The hES gene was expressed in different culture conditions based on the BBD. The hES mRNA expression level was investigated with quantitative real-time PCR. The combined effect on gene expression of different culture conditions, including cell density before induction, inducer concentration, and post-induction time, was also evaluated. In addition, for further confirmation of the expression of the gene of interest, we carried out sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analyses of optimal culture conditions.

3. Materials and Methods {#sec200305}
========================

3.1. Reagents {#sec200296}
-------------

Enzymes, including NcoI, XhoI, T4DNA ligase, Pfu DNA polymerase, gene ruler DNA ladder mix, and PageRuler unstained protein, were obtained from Fermentas-Thermo Fisher Scientific (Burlington, Ontario, Canada). Mini PlusTM plasmid DNA extraction kits and Viogene^®^ gel/PCR DNA isolation system kits were purchased from Viogene (New Taipei, Taiwan). PCR reagents were purchased from Cinnagen (Tehran, Iran). Agar, tryptone, yeast extract, kanamycin, ampicillin, and isopropyl-D-1-thiogalactopyranoside (IPTG) were obtained from Sigma-Aldrich (St. Louis, MO, USA), and prestained protein ladder was obtained from Sinaclon (Tehran, Iran). All chemicals used for SDS-PAGE were purchased from Merck (Darmstadt, Germany). TRIzol^®^ reagent was obtained from Life technologies (Carlsbad, CA, USA), and the two-step RT-PCR kit was from Vivantis technologies (Kuala Lumpur, Malaysia). SYBR Green I stain and SYBR Green PCR master mix were purchased from applied Biosystems (Foster City, CA, USA). Rabbit anti-endostatin polyclonal antibody (ab3453), goat anti-rabbit IgG H and L (HRP) (ab6721), and ECL Western blotting substrate (ab65623) were purchased from Abcam (Cambridge, MA, USA).

3.2. Bacterial Strains, Plasmids, Cell Lines, and Media {#sec200297}
-------------------------------------------------------

The *E. coli* strains DH5α and BL21 (DE3) (Pasteur Institute, Iran) were used as cloning and expression hosts, respectively. The expression vector pET26b (+) was obtained from Pasteur institute (Iran). The clone JET™ PCR cloning kit was from Fermentas-Thermo Fisher Scientific (Waltham, MA, USA), and primers were from ShineGene (Shanghai, China). In addition, the synthetic construct of interest was prepared by ShineGene (Shanghai, China) as a cloned sequence in the pUC57 plasmid.

3.3. Construction of Synthetic Gene and Amplification {#sec200298}
-----------------------------------------------------

The hES coding sequence from the human collagen XVIIIa gene (GenBank accession no. AF184060.1) was taken for codon optimization. Gene optimization and synthesis was done by ShineGene bio-technologies company (Shanghai, China). This construct was sub-cloned in pUC57, including these sequences: NdeI restriction site, alkaline phosphate signal peptide coding sequence (GenBank accession No. M 13763.1), hES coding sequence, and XhoI restriction site.

The hES gene was amplified using pUC57-phoA sp-hES as a template. PCR was performed using the Eppendorf thermal cycler with a set of primers in a total volume of 40 μL. The reaction mixture contained 4 μL of 10 × PCR buffer, 4 μL of MgCl2 (20 mM), 0.7 μL for each dNTP (2.5 mM), 1.5 μL plasmid DNA, 0.6 μL of each primer, and 1 μL of Pfu DNA polymerase (5 units/μL). The program for PCR was one cycle at 95°C for 5 minutes, 30 cycles with denaturation at 95°C for 35 seconds, annealing at 60°C for 40 seconds, then 1 minute at 72°C, and the final extension at 72°C for 7 minutes. The amplification products were electrophoresed on the 1% agarose gel and visualized after SYBR green I staining. The sequences of primers were hES F, TCATCACCACCATGGCGCACTCTCACCG and hES R: GATCCGATAATTTGGCTCGAGTCA. The unique NcoI and XhoI sites (underlined bases) were added to the amplified hES synthetic gene using these primers. In addition, to avoid frame-shifting during the translation of the hES transcript, two nucleotides (CG, bolded bases) were added after the NcoI site.

3.4. Constructing the hES Expression Vector {#sec200299}
-------------------------------------------

The NcoI-hES-XhoI amplified fragments were purified with a Viogene^®^ Gel/PCR DNA Isolation kit and inserted into the pJET1.2/blunt cloning vector (between nucleotides 371 and 372). The *E. coli* DH5α competent cells were transformed by the calcium chloride method ([@A34091R11]) with the recombinant plasmid (pJET-hES) for plasmid amplification. For confirmation of successful transformation, a single colony of transformants was grown in 3 mL of LB medium containing ampicillin (100 µg/mL), followed by colony PCR. For further confirmation, clones containing recombinant vectors were analyzed by the restriction enzyme digestion and sequencing method, using the abovementioned primers.

Next, the pJET-hES and the pET26b (+) vector were double-digested with the NcoI and the XhoI restriction enzymes. The hES gene was then inserted just after a pelB leader sequence in the expression vector pET26b (+) with a T7 promoter to secrete the recombinant hES into the *E. coli* periplasm. The recombinant vectors were transformed into the competent *E. coli* DH5α by the calcium chloride method ([@A34091R11]). Transformants were selected on LB agar containing kanamycin (50 µg/mL), and the clones containing the hES gene were confirmed by colony PCR. Subsequently, in order to re-confirm the clone, a single colony of *E. coli* cells carrying the recombinant plasmid was grown in 3 mL LB medium containing kanamycin. After extraction of plasmid, restriction enzyme digestion and sequencing were done. Following the confirmation by sequencing, the constructs were transformed into *E. coli* BL21 (DE3) competent cells, and were selected on LB agar as described above. The bacterial stocks were kept at -70°C in 25% (v/v) glycerol for long-term usage.

3.5. Media and Cultivation Conditions {#sec200300}
-------------------------------------

LB agar containing kanamycin (50 µg/mL) was used to grow *E. coli* BL21/pET26-hES. The pH was adjusted to 7.4 ± 0.2 prior to autoclaving for 15 minutes at 121°C. For all experiments, the pre-inocula were cultured overnight at 200 rpm and 37°C using LB medium. To evaluate whether the hES gene was expressed successfully, for all experiments, a transformed single colony was inoculated in 5 mL of LB medium supplemented with kanamycin (50 µg/mL), and incubated overnight at 37°C in a shaking (200 rpm) incubator. Then, 2 ml of starter culture was transferred into 500 mL Erlenmeyer flasks with 50 mL of the same broth containing kanamycin (50 µg/mL), and incubated in shaker incubator (37°C, 200 rpm). Cell density at induction time, IPTG concentration, and post-induction (harvesting) time for each experiment were defined according to the BBD, as described below. All experiments were conducted in duplicate.

3.6. Experimental Design Using RSM {#sec200301}
----------------------------------

RSM based on the BBD was employed to optimize culture conditions for the expression of the hES gene in *E. coli* BL21 (DE3) in a shake flask. The independent variables, including inducer concentration (X~1~), post-induction time (X~2~), and cell density before induction (X~3~), were tested at three different levels, as shown in [Table 2](#tbl50668){ref-type="table"}. The practical level of investigation is described in [Table 3](#tbl50669){ref-type="table"}. All experiments were done in triplicate, and the average rhES mRNA expression levels were considered as the experimental data. These data were evaluated statistically by regression analysis using the following second-order polynomial:
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Where Y is the predicted response (rhES mRNA expression level); X~1~, X~2~, and X~3~ are independent variables (inducer concentration, post-induction time, and cell density, respectively); β~0~ is a constant coefficient; β~1~, β~2~, and β~3~ are linear coefficients; β~12~, β~13~, and β~33~ are the interaction coefficients; and β~11~, β~22~, and β~33~ are the quadratic coefficients. For one-way analysis of variance (ANOVA) and RSM, MinitabTM version 17.1 software (Minitab Inc., PA, USA) was used. Also, in order to understand the optimal culture conditions and the interactions of different variables, a three-dimensional (3D) response surface plot and contour and correlation plots were generated.

###### Primers Used in This Study

  Primers                                                 Sequence                           Product Size
  ------------------------------------------------------- ---------------------------------- --------------
  **hES**                                                                                    592 bp
  Forward                                                 5′TCATCACCACCATGGCGCACTCTCACCG3′   
  Reverse                                                 5′GATCCGATAATTTGGCTCGAGTCA3′       
  **hES** ^**[a](#fn53679){ref-type="table-fn"}**^                                           146 bp
  Forward                                                 5′GCTGTCTGGTGGTATGCGTG3′           
  Reverse                                                 5′CACGGTCAGCACGACGAAC3′            
  **16s rRNA** ^**[a](#fn53679){ref-type="table-fn"}**^                                      98 bp
  Forward                                                 5′ATTGACGTTACCCGCAGAAG3′           
  Reverse                                                 5′CTTTACGCCCAGTAATTCCGAT3′         

^a^Primers used for real-time PCR

###### Independent Variables and Coded Values of Variables Used in the BBD

  Independent Variable         Symbol   Unit   Code Level         
  ---------------------------- -------- ------ ------------ ----- -----
  **IPTG concentration**       X~1~     mM     0.2          0.6   1
  **Post-induction time**      X~2~     h      4            7     10
  **Cell density (OD~600~)**   X~3~     \-     0.8          1.1   1.4

###### BBD With Measured and Predicted Response of hES mRNA Expression Level^[a](#fn53677){ref-type="table-fn"}^

  Run      X~1~   X~2~   X~3~   Actual, %^[b](#fn53678){ref-type="table-fn"}^   Predicted, %
  -------- ------ ------ ------ ----------------------------------------------- --------------
  **1**    0.2    4      1.1    71.52                                           92.09
  **2**    1      4      1.1    204.32                                          200.04
  **3**    0.2    10     1.1    207.52                                          211.80
  **4**    1      10     1.1    208.80                                          188.23
  **5**    0.2    7      0.8    272.96                                          261.13
  **6**    1      7      0.8    295.84                                          308.86
  **7**    0.2    7      1.4    92.64                                           79.62
  **8**    1      7      1.4    104.48                                          116.27
  **9**    0.6    4      0.8    289.92                                          281.19
  **10**   0.6    10     0.8    306.24                                          313.78
  **11**   0.6    4      1.4    80.32                                           72.77
  **12**   0.6    10     1.4    139.36                                          148.1
  **13**   0.6    7      1.1    376.16                                          332.64
  **14**   0.6    7      1.1    312.80                                          332.64
  **15**   0.6    7      1.1    308.96                                          332.64

^a^X~1~, IPTG concentration; X~2~, post-induction time; X~3~, cell density before induction (OD~600~).

^b^Mean of duplicate observations.

3.7. RNA Extraction and Reverse Transcription {#sec200302}
---------------------------------------------

A volume of 10^7^ cells was sampled from the flasks under the different growth conditions, and pelleted by centrifugation. Then, 1 mL of TRIzol^®^ Reagent was added to the resulting cells and the extraction process was performed according to the manufacturer's instructions. The concentration and quantity of RNA were evaluated based on OD260/280 ratio measurements and agarose gel (1%) electrophoresis, respectively. In order to synthesize cDNA from total RNA, reverse transcription of RNA was performed in a final volume of 20 μL containing Vivantis RT enzyme mix I (0.5 µL), random hexamer primers (0.5 µL from 100 uM), buffer RT enzyme (2 µL), and 1 μg of total RNA. Subsequently, the samples were incubated at 65°C for 10 minutes and 42°C for 30 minutes. Reverse transcriptase was inactivated by heating at 85°C for 5 minutes, followed by cooling at 4°C for 5 minutes.

3.8. Quantitative Real-Time PCR Assay {#sec200303}
-------------------------------------

The level of hES mRNA expression was determined with the quantitative real-time PCR technique using power SYBR-green PCR master mix, by means of the step-one real-time PCR system (applied biosystems, Foster city, CA, USA). For real-time PCR, hES primers were designed based on optimized hES sequences, and 16s rRNA were used. These primers were designed using Primer3 (version 0.4.0). The forward and reverse primer sequences of hES and 16s RNA are shown in [Table 1](#tbl50670){ref-type="table"}. The 16s rRNA mRNA was calculated as the internal standard control gene by specific primers.

A 146-bp amplicons were generated for hES, and 98-bp amplicons were generated for 16s rRNA, in 20-μL reaction mixtures containing 5 pmol of each of the forward and reverse primers for 16s rRNA or for hES; 10 μL of Power SYBR green PCR master mix and 2 μL of the cDNA was used. The program for the real-time PCR reaction included an initial denaturation step at 95°C for 5 minutes and 40 cycles of denaturation (95°C for 15 seconds), then annealing (60°C for 60 seconds).

To verify the specificity of the fragments, melting curves were determined for each reaction from 60 - 95°C, with data collection at each 0.3°C increment. The 16s rRNA gene, expressed at a constant rate under our conditions, was used as reference gene to normalize the data. After normalization to the reference gene 16s rRNA, the expression level of hES for each different growth condition was analyzed with the 2-ΔΔCT method. Each DNA sample was divided so that hES and 16s rRNA could be amplified in parallel, and the reactions were done in duplicate with equal amounts of starting material.

3.9. Protein Expression Analysis {#sec200304}
--------------------------------

The expressed rhES of optimal culture conditions was checked using SDS-PAGE under reduced conditions ([@A34091R11]). In addition, western blot analysis was applied for further identification of produced rhES using rabbit anti-endostatin polyclonal antibody and goat anti-rabbit IgG H and L (HRP). Proteins were visualized using incubation with ECL Western Blotting Substrate.

4. Results {#sec200309}
==========

4.1. Construction and Amplification of the Synthetic hES Gene {#sec200306}
-------------------------------------------------------------

The wild-type hES gene has 31 rare codons, including 3CGG, 3AGG for arginine, 8CCC for proline, 4 TCC, 2 TCA, 1 AGT, 4TCG for serine, and 6 GGG for glycine. These codons were replaced with preferred *E. coli* codons in synthetic hES. The codon adaptation index (CAI) used to estimate the adaptation of codon-optimized hES to *E. coli* was 0.878. The optimized gene was 75.8% identical to the wild-type hES gene. Subsequently, the hES gene was amplified using specific primers and pUC57-phoA sp-hES as a template, showing a 592-bp band on 1% agarose gel ([Figure 1A](#fig36912){ref-type="fig"}). This fragment contained the hES coding sequence (555 bp) and the NcoI and XhoI restriction sites.

![Amplification of hES Coding Sequence and Construction of Expression Vector\
A, Amplification of hES coding sequence using Pfu DNA polymerase. Lane 1: gene ruler DNA ladder mix (thermo scientific); lane 2: negative control; lane 3: amplified ORF of hES (592 bp). B, Construction of the pET26b-hES vector.](jjm-09-08-34091-g001){#fig36912}

4.2. Construction of the pET26b-rhES Expression Vector {#sec200307}
------------------------------------------------------

The plasmid pET26b (+) was used to construct expression vectors. The protein-coding region of the hES gene was inserted between the NcoI and XhoI sites of the pET26 (+). The recombinant pET26b (+) - hES contained a T7 promoter, a Lac operon, an N-terminal pelB signal sequence, multiple cloning sites, the rhES encoding gene, and the T7 terminator. Following the transformation of *E. coli* BL21 (DE3), the positive clones were selected on LB agar containing kanamycin (50 µg/mL). A sequencing analysis of the recombinant pET26b (+) - hES plasmid with the abovementioned primers confirmed that there were no amplification errors or frame shifts in the sequence of the cloned hES gene. The construction of the expression vector is presented in [Figure 1B](#fig36912){ref-type="fig"}.

4.3. Evaluation of Culture Conditions for the mRNA Expression Level Using RSM {#sec200308}
-----------------------------------------------------------------------------

RSM was applied to evaluate optimal culture conditions for the mRNA expression level of the synthetic hES gene in *E. coli* BL21 (DE3). BBD, an efficient design tool for fitting second-order models under RSM, was used to investigate the effect of three variables, including cell density before induction, IPTG concentration, and post-induction time, which influence the mRNA expression level of hES.

The actual and predicted results for hES mRNA expression levels are summarized in [Table 3](#tbl50669){ref-type="table"}. The hES mRNA expression levels varied, in the range of 71.52% - 376.16%. The ANOVA for the adjusted model revealed that hES expression was significantly affected by the linear and quadratic coefficients and their interactions, except for the interaction factors of X~1~X~3~ and X~2~X~3~ ([Table 4](#tbl50671){ref-type="table"}). The effects of the inducer concentration (coefficient = 21.09, P = 0.001) and post-induction time were positive (coefficient = 26.98, P \< 0.001), whereas the cell density before induction was negative (coefficient = -93.52, P \< 0.001), and the same results were observed with X~1~X~1~, X~2~X~2~, X~3~X~3~, and X~1~X~2~. To estimate the optimal region of hES mRNA expression, second-order models were fitted to the hES mRNA observed results ([Table 3](#tbl50669){ref-type="table"}). The model is described by [Equation 2](#EQ6444){ref-type="disp-formula"}, where the variables are specified in their original units as follows:
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Where Y is the response variable (hES mRNA level), and X~1~, X~2~, and X~3~ are the independent variables (inducer concentration, post-induction time, and cell density before induction, respectively). The fit of the model was evaluated by the determination coefficient (R^2^). The R^2^ value was 0.967, indicating that 96.7% of the total variability in the response could be well-described by the new model. The adjusted determination coefficient (adj. R^2^) was 0.9521, and the F-value was 65.07 (D.F = 9) ([Table 4](#tbl50671){ref-type="table"}). The scatterplot of the predicted versus actual rhES mRNA expression level is shown in [Figure 2](#fig36913){ref-type="fig"}. The actual value is the result obtained for a specific treatment, and the predicted value is obtained from the independent variables in the Box-Behnken model. The model predicted a maximum level of 374.54% hES mRNA, with an inducer concentration (IPTG) of 0.64 mM, a post-induction time of 7.27 hours, and cell density before induction (OD~600~) of 0.85. Therefore, the ANOVA results indicated the satisfactory adjustment of the quadratic models to the actual data.

![Diagnostic Plots for Estimating the Adequacy of the Regression Model\
A, Correlation between predicted and actual values for hES mRNA expression; B; the studentized and normal percentage probability plot of hES mRNA expression.](jjm-09-08-34091-i001){#fig36913}

The interactive effects of variables on hES expression were plotted in the form of contour and 3D response surfaces, as illustrated in [Figure 3A - C](#fig36914){ref-type="fig"}. Response surface contour plots and 3D graphs demonstrated accurate information about the relationship between the actual levels and the response of each independent variable. The interactions of IPTG and post-induction time with hES mRNA gene expression are shown in [Figure 3A](#fig36914){ref-type="fig"}. The optimum condition for hES expression was found to be at an IPTG concentration of 0.6 mM and a post-induction time of 7 hours. Moreover, the combined impact of IPTG concentration and cell density on hES expression is shown in [Figure 3B](#fig36914){ref-type="fig"}; the combined impact of post-induction time and cell density on hES mRNA gene expression is depicted in [Figure 3C](#fig36914){ref-type="fig"}. These plots show that an IPTG concentration of \< 0.6 mM and a post-induction time of 7 hours were favorable for hES mRNA expression, while increased OD~600~ resulted in decreased hES mRNA expression.

![Response Surface Plots (left) and Contour Plots (right) of rhES mRNA Revealed the Relationship Between the Response and Actual Levels of Each Independent Variable\
A, The effect of inducer concentration (IPTG) and post-induction time on rhES mRNA; B, the effect of inducer concentration (IPTG) and cell density before induction time on rhES mRNA; C, the effect of post-induction time and cell density before induction time on rhES mRNA.](jjm-09-08-34091-g002){#fig36914}

The expressed rhES presented approximately 20 kDa on SDS-PAGE ([Figure 4A](#fig36915){ref-type="fig"}), which was compatible with the theoretical molecular mass, and it was found to be immune-reactive when evaluated by western blot using rabbit anti-endostatin polyclonal antibody ([Figure 4B](#fig36915){ref-type="fig"}). Finally, the results of SDS-PAGE and western blot confirmed the successful expression of hES mRNA in *E. coli* BL21 (DE3).

![SDS-PAGE and Western Blot Analysis of Expressed hES Gene\
A, SDS-PAGE (12%); B, Western blot. Lane 1, protein marker; lane 2, total protein before induction; lane 3, total protein after induction in recombinant pET26b.](jjm-09-08-34091-g003){#fig36915}

###### ANOVA for Response Surface Quadratic Model for hES mRNA Expression Level^[a](#fn53680){ref-type="table-fn"}^

  Source                        D.F.   S.S.     M.S.     F-Value   Coef     SE Coef   T-Value   P-Value
  ----------------------------- ------ -------- -------- --------- -------- --------- --------- ----------
  **Model**                     9      270569   30063    65.07     \-       \-        \-        \< 0.001
  **Constant**                         \-       \-       \-        332.64   8.77      37.91     \< 0.001
  **X** ~**1**~                 1      7120     7120     15.41     21.09    5.37      3.93      0.001
  **X** ~**2**~                 1      11646    11646    25.21     26.98    5.37      5.02      \< 0.001
  **X** ~**3**~                 1      139947   139947   302.92    -93.52   5.37      -17.4     \< 0.001
  **X** ~**1**~ **X** ~**1**~   1      54672    54672    118.34    -86.04   7.91      -10.88    \< 0.001
  **X** ~**2**~ **X** ~**2**~   1      39955    39955    86.48     -73.56   7.91      -9.30     \< 0.001
  **X** ~**3**~ **X** ~**3**~   1      22441    22441    48.58     -55.13   7.91      -6.97     \< 0.001
  **X** ~**1**~ **X** ~**2**~   1      8649     8649     18.72     -32.88   7.6       -4.33     \< 0.001
  **X** ~**1**~ **X** ~**3**~   1      61       61       0.13      -2.77    7.6       -0.36     0.719
  **X** ~**2**~ **X** ~**3**~   1      913      913      1.98      10.68    7.6       1.41      0.175
  **Lack of fit**               3      3536     1179     3.51      \-       \-        \-        0.038
  **Pure error**                17     5704     336      \-        \-       \-        \-        \-
  **Total**                     29     279809   \-       \-        \-       \-        \-        \-

^a^X~1~, IPTG concentration; X~2~, post-induction time; X~3~, cell density in OD~600~; D.F., degrees of freedom; S.S, sum of squares; M.S., mean of squares; Coef., coefficient; SE.Coef., standard error coefficient; F-value, Fisher's test; P-value, probability distribution value. The correlation coefficient (R^2^) was 0.967 and the adjusted R^2^ was 0.9521.

5. Discussion {#sec200310}
=============

Recombinant human endostatin protein is an attractive candidate as an anti-cancer agent with high efficacy, few side effects, and no reported drug resistance ([@A34091R12]). Transcription of a cloned gene is the first step in gene expression that leads to protein production ([@A34091R6]). To obtain high yields of a recombinant protein, the protein-coding gene is usually expressed at the highest possible level ([@A34091R13]), so improving the involved factors in gene expression can be useful. A few studies have employed qRT-PCR to study the effects of the involved factors in gene expression in eukaryotic cells ([@A34091R14], [@A34091R15]). For the first time, we utilized this technique to evaluate effective factors in the expression of synthetic hES gene, which is involved in the synthesis of rhES protein. In the present study, hES gene expression, which was cloned in pET26b plasmid, was assessed under the experimental conditions using the BBD. The interest-gene expression was also confirmed by western blot. This is the first attempt to consider the influence of cell density before induction, inducer concentration, and post-induction time alone, as well as each factor's interactions with the others, with regard to increasing hES mRNA expression levels.

Several hosts, such as *E. coli*, yeast, mammalian cells, and baculovirus, have been used to produce rhES ([@A34091R2], [@A34091R3]). Expressing heterologous proteins in the *E. coli* system has some advantages over other systems, including a high expression level, rapid growth, and low cost ([@A34091R16], [@A34091R17]). However, despite the many advantages of the *E. coli* expression system, high-level expression is not easily achieved. Several common factors attenuate protein expression by *E. coli*, including codon bias, gene product toxicity, insolubility, mRNA secondary structure, and mRNA instability ([@A34091R18]-[@A34091R20]). In contrast, several reports have proposed the use of synthetic genes to increase expression efficiency ([@A34091R21]). Considering the factors involved in heterologous protein expression, the optimized synthetic hES gene was applied to amplify the hES gene, followed by cloning and expression in *E. coli* BL21 (DE3) in the current study.

Researchers have established that culture conditions significantly affect the recombinant protein expression level ([@A34091R22], [@A34091R23]) that results from mRNA expression. The altered protein expression level could be related to the expression level of the protein-coding gene ([@A34091R13]). In order to optimize the culture conditions for hES gene expression, three factors were selected. The conventional method is time-consuming, analyzes only one variable at one time, and is unable to analyze the interactions between the different factors ([@A34091R8]). Therefore, the BBD was applied instead.

The BBD helps in the analysis of many variables using the lowest number of examinations, testing the statistical significance of the variable and validating the interactions between the variables ([@A34091R8], [@A34091R21]). Therefore, this method was applied to achieve the optimal conditions for the expected responses and to reduce the number of required examinations, and was used to predict the hES mRNA expression level. In this experiment, the BBD results revealed that the level of hES mRNA expression was significantly correlated with post-induction time, IPTG concentration, and cell density before induction (P \< 0.05). The BBD results are given by [Equation 2](#EQ6444){ref-type="disp-formula"}.

It has been proven that a large F-value indicates that most of the variation can be described by a regression equation, and a P \< 0.05 demonstrates that the model is considered to be statistically significant ([@A34091R8]). Our ANOVA results confirmed that the model was adequate for representing the experimental data in the current study. The fit of the model can be confirmed by the correlation coefficient (R^2^) along with an acceptable agreement with the adjusted correlation coefficient R^2^~adj~ ([@A34091R24]). The values of R^2^ and R^2^~adj~ were close to 1, which clearly indicates that the obtained experimental responses adequately fit with the model ([Figure 2B](#fig36913){ref-type="fig"}). These findings indicated a strong correlation between the experimental and predicted values ([Figure 2A](#fig36913){ref-type="fig"}) ([@A34091R8]).

In the present study, the hES mRNA expression level was markedly improved at the optimum point of culture conditions given by the BBD model, and any change in the values of the optimized factors resulted in decreased hES mRNA expression. As previously reported, any change in the optimum culture conditions results in an altered growth rate of *E. coli*, which in turn affects the gene expression levels ([@A34091R22], [@A34091R24]). The aforementioned factors in the present investigation are completely explained as follows:

IPTG was found to be an effective factor in hES expression. Its optimum concentration was 0.64 mM, and any change in this concentration caused decreased hES mRNA levels. It has been reported that the concentration of IPTG for the induction of gene expression varies from 0.005 mM to 5 mM ([@A34091R7]). In addition, low IPTG concentrations result in ineffective induction, while high IPTG concentrations result in a significantly reduced growth rate of *E. coli* ([@A34091R25], [@A34091R26]). Therefore, it is suggested that the determination of the optimum IPTG concentration is important in gene expression.

Post-induction time was another effective factor with a positive influence in this study. The hES mRNA expression level was increased with a longer post-induction time, but post-induction times beyond the optimum point caused decreased mRNA levels. It has been established that the effects of post-induction time depend on case-specific expression ([@A34091R4]). Therefore, optimizing the post-induction time is strongly suggested.

With regard to cell density before induction, a lower cell density caused a lower level of hES mRNA in this study. Induction is usually performed at the early or mid-log phase. However, some reports recommend induction in the late-log phase or even in the stationary phase ([@A34091R27]). However, Manderson et al. reported that the effects of cell density before induction are case-specific ([@A34091R28]). Therefore, it is recommended that cell density should be optimized in each case.

Based on these findings, we conclude that optimizing the three important factors of IPTG concentration, post-induction time, and cell density before induction can improve hES mRNA yield in the *E. coli* expression system.
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